Your browser doesn't support javascript.
loading
Dapagliflozin Attenuates Myocardial Fibrosis by Inhibiting the TGF-ß1/Smad Signaling Pathway in a Normoglycemic Rabbit Model of Chronic Heart Failure.
Chen, Xuefeng; Yang, Qian; Bai, Wenlou; Yao, Wenjing; Liu, Litian; Xing, Yuanyuan; Meng, Cunliang; Qi, Peng; Dang, Yi; Qi, Xiaoyong.
Affiliation
  • Chen X; Department of Internal Medicine, Hebei Medical University, Shijiazhuang, China.
  • Yang Q; Department of Cardiology Center, Hebei General Hospital, Shijiazhuang, China.
  • Bai W; Department of Cardiology Center, Hebei General Hospital, Shijiazhuang, China.
  • Yao W; Department of Cardiology Center, Hebei General Hospital, Shijiazhuang, China.
  • Liu L; Department of Cardiology Center, Hebei General Hospital, Shijiazhuang, China.
  • Xing Y; Department of Cardiology Center, Hebei General Hospital, Shijiazhuang, China.
  • Meng C; Department of Cardiology Center, Hebei General Hospital, Shijiazhuang, China.
  • Qi P; Department of Cardiology Center, Hebei General Hospital, Shijiazhuang, China.
  • Dang Y; Department of Cardiology Center, Hebei General Hospital, Shijiazhuang, China.
  • Qi X; Department of Cardiology Center, Hebei General Hospital, Shijiazhuang, China.
Front Pharmacol ; 13: 873108, 2022.
Article in En | MEDLINE | ID: mdl-35645838
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: China